Navigation Links
Bionic Vision Australia puts bionic eye in sight
Date:3/30/2010

Bionic Vision Australia (BVA) today unveils their wide-view neurostimulator concept a bionic eye that will be implanted into Australia's first recipient of the technology.

The prototype bionic eye, developed by BVA researchers at the University of New South Wales and unveiled today at the BVA consortium's official launch at the University of Melbourne, will deliver improved quality of life for patients suffering from degenerative vision loss caused by retinitis pigmentosa and age-related macular degeneration.

The device, which is currently undergoing testing, consists of a miniature camera mounted on glasses that captures visual input, transforming it into electrical signals that directly stimulate surviving neurons in the retina. The implant will enable recipients to perceive points of light in the visual field that the brain can then reconstruct into an image.

Research Director of Bionic Vision Australia and Professor of Engineering at the University of Melbourne, Professor Anthony Burkitt says the device will deliver life-changing vision for recipients.

"We anticipate that this retinal implant will provide users with increased mobility and independence, and that future versions of the implant will eventually allow recipients to recognise faces and read large print," he says.

Bionic Vision Australia Chairman, Professor Emeritus David Penington AC says the BVA team's outstanding expertise will be the key to delivering their ambitious goal of providing bionic vision within the next five years.

"This is an exciting moment in our venture. The team's success is based on our world class multi-disciplinary approach which uses vision clinicians, retinal surgeons, neuroscientists, biomedical and electrical engineers from across the nation," he says.

BVA is a partnership of world-leading Australian research institutions collaborating to develop an advanced retinal prosthesis, or bionic eye, to restore the sense of vision to people with degenerative or inherited retinal disease. The partners of Bionic Vision Australia are the University of Melbourne, the University of New South Wales, the Bionic Ear Institute, the Centre for Eye Research Australia and NICTA.

In December 2009 Bionic Vision Australia (BVA) was awarded $42 million from the Federal Government. Professor Penington says the grant, provided over four years, will take the team to the point where commercial development of an implant at the back of the eye, responding to wireless transmission of vision, will become a reality.

Retinitis Pigmentosa sufferer Leighton Boyd says this exciting development gives him hope that he will once again be able to see the faces of his loved ones.


'/>"/>

Contact: Emma ONeill
eaoneill@unimelb.edu.au
61-383-447-220
University of Melbourne
Source:Eurekalert

Related biology news :

1. Seeing a bionic eye on medicines horizon
2. Study uses Chinese wolfberries to improve vision imperfections caused by type-2 diabetes
3. Scientists at UCSB discover 600-million-year-old origins of vision
4. Way to go: MBL scientists identify driving forces in human cell division
5. Butterfly vision, wing colors linked, UCI study finds
6. Researchers envision high-tech applications for multiferroic crystals
7. Sweet! -- sugar plays key role in cell division
8. Scientists using X-ray vision to produce more nutritious flour
9. BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division
10. BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division
11. CBS and OMD Partner to Provide the Agency With Access to the Networks Television City Research Facility in Las Vegas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology: